Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Norwich Names Pharma Development VP | Contract Pharma
Breaking News, Promotions & Moves

Norwich Names Pharma Development VP

Arnold to lead product development and technical services

Kristin Arnold, Ph.D. has been appointed vice president of product development and technical services (PDTS) at Norwich Pharmaceuticals. Dr. Arnold will provide strategic leadership for the PDTS group that includes R&D, GMP pilot scale manufacturing, analytical development and validation, and testing services. She reports to chief executive officer, Doug Drysdale.
 
Prior to joining the company, Dr. Arnold held positions with URL Pharma as senior vice president of Product Development, Alpharma as senior director R&D, FMC Corp., Ecogen, and Monsanto.
 
“We are pleased to welcome Kristin Arnold to Norwich and look forward to her contributions to the PDTS group and the organization,” said Mr. Drysdale. “Her expertise in product development from product conception through market launch will be an advantage for our customers and she will be a strong addition to our leadership team.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters